CEO: Dr. Andrew Sledziewski

Dr. Sledziewski (CEO) brings more than 25 years of experience managing biotechnology research organizations.  He  has spent the last ten years with Epigenomics, an international DNA methylation company, managing its research and IP.

Scientific Advisor : Dr. Theo deVos

Dr. Theo deVos has managed a wide variety of scientific and technical functions in biotechnology companies.  Most recently he has been part of the discovery, design, development and commercialization of Epi proColon, a first-in-class molecular diagnostic test based on DNA methylation.